Non-Hodgkin Lymphoma Clinical Trials

Find Non-Hodgkin Lymphoma Clinical Trials Near You

New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman Disease

Status: Recruiting
Location: See location...
Intervention Type: Procedure, Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Persons living with HIV (PLWH) in sub-Saharan Africa (SSA), lymphadenopathy often portends one of a number of life-threatening diseases including tuberculosis, lymphoma, and multicentric Castleman disease (MCD). Overcoming these delays and missed diagnoses requires new approaches to identify lymphoma and MCD.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 1
Healthy Volunteers: f
View:

• Age ≥1 year old and body weight of ≥ 10 kg.

• HIV-infected.

• Unexplained lymphadenopathy with at least one lymph node ≥2 cm that is amenable to biopsy.

• Willing and able to give informed consent if the subject is 18 years of age or older, adolescent assent and legal guardian consent for subjects 15-17 years of age, pediatric assent and legal guardian consent for subjects 7-14 years of age, or legal guardian consent for pediatric subjects less than 7 years of age.

Locations
Other Locations
Malawi
Lighthouse Trust HIV Centers of Excellence
RECRUITING
Lilongwe
Contact Information
Primary
Matthew Painschab, MD
mapain@iu.edu
(317) 278-0626
Backup
Yuri Fedoriw, MD
Yuri.Fedoriw@unchealth.unc.edu
1 984-974-8320
Time Frame
Start Date: 2025-03-17
Estimated Completion Date: 2028-12
Participants
Target number of participants: 500
Treatments
Experimental: HIV-infected patients with unexplained lymphadenopathy
HIV-infected patients in routine clinical care with unexplained lymphadenopathy
Sponsors
Collaborators: UNC Lineberger Comprehensive Cancer Center, National Institutes of Health (NIH)
Leads: Indiana University

This content was sourced from clinicaltrials.gov